Nanomedicine and targeted drug delivery
Course, Master's level, 3FG025
Expand the information below to show details on how to apply and entry requirements.
Autumn 2026 Autumn 2026, Uppsala, 100%, On-campus, English
- Location
- Uppsala
- Pace of study
- 100%
- Teaching form
- On-campus
- Instructional time
- Daytime
- Study period
- 1 October 2026–1 November 2026
- Language of instruction
- English
- Entry requirements
-
150 credits, with 120 credits in biomedicine, pharmaceutical sciences, drug development, natural sciences and/or engineering, including (1) physical chemistry and pharmaceutics 13 credits or (2) Molecular Biopharmaceutics 7.5 credits.
Proficiency in English equivalent to the Swedish upper secondary course English 6.
- Selection
-
Higher education credits (maximum 285 credits)
- Fees
- If you are not a citizen of a European Union (EU) or European Economic Area (EEA) country, or Switzerland, you are required to pay application and tuition fees.
- First tuition fee instalment: SEK 20,625
- Total tuition fee: SEK 20,625
- Application deadline
- 15 April 2026
- Application code
- UU-39001
Admitted or on the waiting list?
- Registration period
- 24 September 2026–1 October 2026
- Information on registration from the department
Autumn 2026 Autumn 2026, Uppsala, 100%, On-campus, English For exchange students
- Location
- Uppsala
- Pace of study
- 100%
- Teaching form
- On-campus
- Instructional time
- Daytime
- Study period
- 1 October 2026–1 November 2026
- Language of instruction
- English
- Entry requirements
-
150 credits, with 120 credits in biomedicine, pharmaceutical sciences, drug development, natural sciences and/or engineering, including (1) physical chemistry and pharmaceutics 13 credits or (2) Molecular Biopharmaceutics 7.5 credits.
Proficiency in English equivalent to the Swedish upper secondary course English 6.
Admitted or on the waiting list?
- Registration period
- 24 September 2026–1 October 2026
- Information on registration from the department
About the course
The course provides an in-depth understanding of nanomedicine and the design of targeted drug delivery systems, with a focus on patient-centered therapies and controlled, selective drug release. You learn to analyse biological, technological, and regulatory aspects of nanotechnology-based formulations, as well as to plan, conduct, and report experimental and project-based work within the field.
Reading list
No reading list found.